-
公开(公告)号：US20170355781A1
公开(公告)日：2017-12-14
申请号：US15683087
申请日：2017-08-22
Applicant: CCAM BIOTHERAPEUTICS LTD.
Inventor： Gal MARKEL , Tehila BEN MOSHE , Yair SAPIR , Ilana MANDEL , Jacob SCHACHTER , Rona ORTENBERG
CPC classification number: C07K16/42 , A61K35/17 , A61K39/39566 , A61K45/06 , A61K2039/505 , C07K16/3007 , C07K2317/24 , C07K2317/73 , C07K2317/76 , C07K2317/92 , G01N33/686
Abstract: The present invention provides antibodies, as well as molecules having at least the antigen-binding portion of an antibody, recognizing a specific epitope of the protein CEACAM1 and optionally binds also other subtypes of the CEACAM protein family. Disclosed antibodies and antibody fragments are characterized by specific CDR sequences. Methods of production and use in therapy and diagnosis, of such antibodies and antibody fragments are also provided.
-
2.发明申请ANTIBODIES TO CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE (CEACAM) 有权抗肿瘤抗原相关细胞粘附分子的抗体（CEACAM）公开(公告)号：US20140271618A1
公开(公告)日：2014-09-18
申请号：US14350970
申请日：2012-10-10
Applicant: TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. , CCAM BIOTHERAPEUTICS LTD. , RAMOT AT TEL-AVIV UNIVERSITY LTD.
Inventor： Gal Markel , Tehila Ben Moshe , Yair Sapir , Ilana Mandel , Jacob Schachter , Rona Ortenberg
IPC: C07K16/42 , A61K45/06 , A61K35/14 , A61K39/395 , G01N33/68
CPC classification number: C07K16/42 , A61K35/17 , A61K39/39566 , A61K45/06 , A61K2039/505 , C07K16/3007 , C07K2317/24 , C07K2317/73 , C07K2317/76 , C07K2317/92 , G01N33/686
Abstract: The present invention provides antibodies, as well as molecules having at least the antigen-binding portion of an antibody, recognizing a specific epitope of the protein CEACAM1 and optionally binds also other subtypes of the CEACAM protein family. Disclosed antibodies and antibody fragments are characterized by specific CDR sequences. Methods of production and use in therapy and diagnosis, of such antibodies and antibody fragments are also provided.
Abstract translation: 本发明提供抗体以及至少具有抗体的抗原结合部分的分子，其识别蛋白质CEACAM1的特异性表位，并且任选地也可以结合CEACAM蛋白家族的其它亚型。 公开的抗体和抗体片段的特征在于特异性CDR序列。 还提供了这种抗体和抗体片段的生产和用于治疗和诊断的方法。
-
Patent Agency Ranking
公开(公告)号：US10550196B2
公开(公告)日：2020-02-04
申请号：US15306664
申请日：2015-04-27
Applicant: CCAM BIOTHERAPEUTICS LTD.
Inventor： Tehila Ben-Moshe , Yair Sapir , Ilana Mandel , Gal Markel , Jacob Schachter , Rona Ortenberg , Francis Joseph Carr , Robert George E. Holgate , Timothy David Jones
IPC: C07K16/42 , C07K16/30 , A61K35/17 , A61K39/395 , A61K45/06 , G01N33/68 , A61K39/00 , G01N33/574 , C07K16/28
Abstract: Humanized antibodies, capable of specific binding to human CEACAM1 molecules containing human-to-murine back-mutations in non-CDR variable regions, and their encoding polynucleotide sequences are provided. Pharmaceutical compositions comprising these antibodies as well as methods of their use in treating and diagnosing cancer and other conditions are also provided.
-
公开(公告)号：US20170044270A1
公开(公告)日：2017-02-16
申请号：US15306664
申请日：2015-04-27
Applicant: CCAM BIOTHERAPEUTICS LTD.
Inventor： Tehila BEN-MOSHE , Yair SAPIR , Ilana MANDEL , Gal MARKEL , Jacob SCHACHTER , Rona ORTENBERG , Francis Joseph CARR , Robert George E. HOLGATE , Timothy David JONES
IPC: C07K16/30 , G01N33/574 , C07K16/28 , A61K35/17 , A61K39/395 , A61K45/06
Abstract: Humanized antibodies, capable of specific binding to human CEACAM1 molecules containing human-to-murine back-mutations in non-CDR variable regions, and their encoding polynucleotide sequences are provided. Pharmaceutical compositions comprising these antibodies as well as methods of their use in treating and diagnosing cancer and other conditions are also provided.
Abstract translation: 提供能够特异性结合含有非CDR区域中的人到鼠反向突变的人CEACAM1分子的人源化抗体及其编码多核苷酸序列。 还提供了包含这些抗体的药物组合物及其用于治疗和诊断癌症和其它病症的方法。
-
公开(公告)号：US10081679B2
公开(公告)日：2018-09-25
申请号：US15039022
申请日：2014-11-25
Applicant: CCAM BIOTHERAPEUTICS LTD.
Inventor： Tehila Ben-Moshe , Yair Sapir , Ilana Mandel , Edna Meilin
IPC: A61K39/395 , C07K16/28 , A61K35/17 , A61K39/00 , A61K35/12
CPC classification number: C07K16/2803 , A61K35/17 , A61K39/39558 , A61K2035/124 , A61K2039/505 , A61K2039/507 , C07K16/2818 , C07K16/2827 , C07K2317/33 , C07K2317/565 , C07K2317/73 , C07K2317/92
Abstract: The present invention provides compositions comprising anti-CEACAM1 antibodies, compositions comprising antibodies capable of inhibiting or blocking the interaction between PD-1 and its ligands, and methods for their combined use in treating cancer.
-
公开(公告)号：US09771431B2
公开(公告)日：2017-09-26
申请号：US14350970
申请日：2012-10-10
Applicant: TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. , CCAM BIOTHERAPEUTICS LTD. , RAMOT AT TEL-AVIV UNIVERSITY LTD.
Inventor： Gal Markel , Tehila Ben Moshe , Yair Sapir , Ilana Mandel , Jacob Schachter , Rona Ortenberg
CPC classification number: C07K16/42 , A61K35/17 , A61K39/39566 , A61K45/06 , A61K2039/505 , C07K16/3007 , C07K2317/24 , C07K2317/73 , C07K2317/76 , C07K2317/92 , G01N33/686
Abstract: The present invention provides antibodies, as well as molecules having at least the antigen-binding portion of an antibody, recognizing a specific epitope of the protein CEACAM1 and optionally binds also other subtypes of the CEACAM protein family. Disclosed antibodies and antibody fragments are characterized by specific CDR sequences. Methods of production and use in therapy and diagnosis, of such antibodies and antibody fragments are also provided.
-
公开(公告)号：US20170166637A1
公开(公告)日：2017-06-15
申请号：US15039022
申请日：2014-11-25
Applicant: CCAM BIOTHERAPEUTICS LTD.
Inventor： Tehila BEN-MOSHE , Yair SAPIR , Ilana MANDEL , Edna MEILIN
IPC: C07K16/28 , A61K39/395 , A61K35/17
CPC classification number: C07K16/2803 , A61K35/17 , A61K39/39558 , A61K2035/124 , A61K2039/505 , A61K2039/507 , C07K16/2818 , C07K16/2827 , C07K2317/33 , C07K2317/565 , C07K2317/73 , C07K2317/92
Abstract: The present invention provides compositions comprising anti-CEACAM1 antibodies, compositions comprising antibodies capable of inhibiting or blocking the interaction between PD-1 and its ligands, and methods for their combined use in treating cancer.
-
-
-
-
-
-
Search Results
7
records
(took 0.015 seconds)
